In the evening of January 14, Tianguang Zhongmao released the revised notice of 2019 annual performance forecast. Previously, it was predicted in the full text of the third quarter report of 2019 that the change range of net profit attributable to shareholders of Listed Companies in 2019 was - 60% - 30% compared with the same period of last year, and the change range of net profit attributable to shareholders of Listed Companies in 2019 was from loss 181 million yuan to loss 316 million yuan.
After the amendment, it is estimated that the net loss attributable to the shareholders of the listed company in 2019 will be 2.158 billion yuan to 3.047 billion yuan, with a loss of 451.5 million yuan in the previous year.
Why is there such a big loss?
Among them, the project inventory of Guangzhou Zhongmao Garden Construction Engineering Co., Ltd., a wholly-owned subsidiary of the company, and the goodwill formed when the company acquired Guangzhou Zhongmao Garden Construction Engineering Co., Ltd. and Dianbai Zhongmao Biotechnology Co., Ltd., a wholly-owned subsidiary of the company in 2015, have obvious impairment risk.
According to the company, in line with the principle of prudence, it is proposed to make provision for impairment of the above-mentioned matters, and the amount of impairment shall be determined after being examined and approved by the accounting firm.
As of the latest closing, the value of Tianguang Zhongmao a stock market is only 3.689 billion, that is to say, the loss in 2019 will almost wipe out the market value.
Tianguang Zhongmao, formerly known as Tianguang fire protection, used to focus on fire protection products and projects. The company was listed on the small and medium-sized board in November 2010. At the end of 2015, the company carried out strategic transformation, acquired Zhongmao garden and Zhongmao biology by issuing shares to purchase assets, and began to merge into the income statement in 2016, officially entering the field of landscape and edible fungi.
After a series of M & A and other operations, Tianguang Zhongmaos main business has shifted from fire protection products to garden construction, and its share price has nearly doubled from 2012 to 2017, becoming a once big bull stock. However, due to cross-border M & A, there are hidden dangers. Now the operating cash flow has been in negative debt crisis for years, and the share price has only one more share left
In 2018, Tianguang Zhongmaos performance changed dramatically. Previously, it was predicted that the profit in 2018 would be 60.79 million to 243 million, and after correction, it is estimated that the loss will be 450 million to 486 million, with a huge difference between before and after.
As the difference between the companys net profit disclosed in the performance notice amendment announcement and performance express and the audited net profit in 2018 is - 512 million and - 558 million respectively, the difference is huge, Tianguang Zhongmao was criticized by Shenzhen Stock Exchange. At the same time, Shenzhen Stock Exchange issued a circular of criticism to Gao HengYuan, then chairman Qiu Maoqi, general manager Huang Ruliang and Su Jiequan, chief financial officer of the company.
Up to now, the number of shareholders of the company is still as high as 50000.
Goodwill impairment again! Kyrgyz holdings disclosed its 2019 annual performance forecast on the evening of April 14. The company is expected to lose 1.5-1.505 billion yuan in 2019, with a net profit of 217 million yuan in the same period of last year.
As for the main reasons for the loss: the company is expected to accrue about 550 million yuan of goodwill impairment provision in 2019; about 280 million yuan of bad debt provision is expected to accrue; 283 million yuan of inventory loss is expected; and 150 million yuan of impairment provision for construction in progress is expected to accrue.
Jilin Pharmaceutical Holding Co., Ltd. has been regarded as snake swallowing elephant by the market for hundreds of millions of pharmaceutical M & A cases before, but it was finally determined by the regulatory authorities as a self directing and self acting drama by the listed companies after the continuous confrontations of the acquirers and questions from the exchange.
On November 27, a punishment decision was posted on the official website of Jilin securities regulatory bureau, which showed that when Jilin Pharmaceutical Holdings released the announcement on the termination of the reorganization of the company and the amended Pharmaceutical Group, it additionally disclosed the information that it will continue to promote the purchase of 100% equity of the amended pharmaceutical industry. And this information also makes the price of Kyrgyz holdings rise and fall for two consecutive days.
In addition to the announcement of Wulongs acquisition, Jiyao Holdings has had several cases of capital operation before, but behind the frequent acquisition actions, the companys performance has never improved.
According to the 2018 annual report of Kyrgyz holdings, Kyrgyz holdings acquired Campbell pharmaceutical, Liaoning Meiluo, Yuanda Kanghua, arida capsule and Puhua pharmaceutical successively in 2018, with a cost of nearly 1 billion yuan and a new goodwill of 854 million yuan.
Shares of the company or delisting
*St Baoqian released the 2019 performance forecast in the evening of January 14, and the company expects that the net profit loss attributable to the shareholders of the listed company in 2019 will be 880 million yuan to 1.02 billion yuan, compared with the loss of 1.689 billion yuan in the same period of last year.
*St Baoqian said that in 2019, the companys capital shortage has not improved, production and operation have not been fully restored to normal, resulting in slow business development, insufficient profitability, and high operating costs due to the companys debt interest, so the company failed to achieve profitability in the reporting period. At the same time, the number of lawsuits filed by small and medium-sized investors against the company continues to increase in 2019, and the company has accrued estimated liabilities for the litigation compensation costs of relevant undecided cases; the subsidiaries of the company are suspected of providing guarantees for 12 loans of 12 enterprises under the leadership of Zhuang min, the original actual controller. The company has previously accrued 198 million yuan that has been transferred, and the company may continue to accrue the rest The estimated liabilities are withdrawn for the illegal guarantee required to fulfill the repayment responsibility.
Due to the negative net assets for two consecutive years and the audit opinion of the audited institution that cannot express an opinion for two consecutive years, * ST Baoqian stock has been suspended from listing on May 24, 2019.
As of the latest data, the number of shareholders of * ST Baoqian is still more than 90000.
Time Wanheng will lose 259 million yuan in 2019
Or will be ST
Time Wanheng releases the 2019 performance forecast. The company expects to achieve a net profit of - 259 million yuan attributable to shareholders of Listed Companies in 2019. In 2018, the performance of listed companies also lost 175 million yuan.
According to the announcement, Jiuyi lithium energy, a time Wanheng holding subsidiary, is expected to lose 383 million yuan in 2019. Among them, it is estimated that the operating loss of Jiuyi lithium energy is about 85 million yuan. In addition, the companys asset impairment signs are obvious, and the performance cannot be fundamentally improved in the short term. Time Wanheng preliminarily determined that the provision for impairment of fixed assets is about 298 million yuan.
Time Wanheng said that Jiuyi lithium energy did not fully estimate the technical difficulty of lithium battery for electric tools, the long time of product target market certification and the complex product certification procedures, which greatly affected the product orders and the capacity utilization rate was insufficient; at the same time, due to the intensified competition, the companys product price was lower than expected.
In 2018, the audited net profit of time Wanheng was - 175 million yuan. If the audited net profit in 2019 is still negative, according to relevant regulations, the companys shares will be subject to delisting risk warning.
As of the latest data, time Wanheng has 13700 shareholders.